Published in Biochem Pharmacol on June 01, 1999
In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6. Br J Clin Pharmacol (2000) 1.08
Biomarkers for antiepileptic drug response. Biomark Med (2011) 0.79
Association analysis of CYP2C9*3 and phenytoin-induced severe cutaneous adverse reactions (SCARs) in Thai epilepsy children. J Hum Genet (2015) 0.77
The effect of polymorphic metabolism enzymes on serum phenytoin level. Neurol Sci (2014) 0.77
Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine. Genomics Proteomics Bioinformatics (2016) 0.76
Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions. Eur J Clin Pharmacol (2017) 0.75
Acute and Chronic Administrations of Rheum palmatum Reduced the Bioavailability of Phenytoin in Rats: A New Herb-Drug Interaction. Evid Based Complement Alternat Med (2012) 0.75
The use of urine to clarify the genotype of a patient with toxic phenytoin concentrations who had undergone peripheral blood stem cell transplantation. Br J Clin Pharmacol (2004) 0.75
Resetting central and peripheral circadian oscillators in transgenic rats. Science (2000) 8.63
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology (1974) 6.53
Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature (1989) 6.07
Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation (1995) 4.48
The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem (1994) 3.75
Natural history of Diagnostic Interview Schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area follow-up. Arch Gen Psychiatry (1997) 3.48
Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol (1994) 3.05
Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation (2001) 3.03
The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics (1996) 3.02
Spred is a Sprouty-related suppressor of Ras signalling. Nature (2001) 2.87
Nerve sprouting and sudden cardiac death. Circ Res (2000) 2.80
Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat Genet (1996) 2.77
Temperature-sensitive mutants of influenza WSN virus defective in virus-specific RNA synthesis. J Virol (1975) 2.72
Microcircuits for night vision in mouse retina. J Neurosci (2001) 2.58
Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin. Clin Pharmacol Ther (2007) 2.54
Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP, a mutagenic substrate for DNA synthesis. J Biol Chem (1993) 2.52
UV-induced skin damage. Toxicology (2003) 2.45
Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation (2000) 2.44
Expression of antigenic determinants of the hemagglutinin gene of a human influenza virus in Escherichia coli. Proc Natl Acad Sci U S A (1981) 2.42
Further isolation and characterization of temperature-sensitive mutants of influenza virus. Virology (1975) 2.42
A comparison of self-report and clinical diagnostic interviews for depression: diagnostic interview schedule and schedules for clinical assessment in neuropsychiatry in the Baltimore epidemiologic catchment area follow-up. Arch Gen Psychiatry (2000) 2.35
The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem (2001) 2.29
Surgical anatomy of the hepatic veins and the inferior vena cava. Surg Gynecol Obstet (1981) 2.12
Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med (1998) 2.12
Plasma endothelin levels in patients with cirrhosis and their relationships to the severity of cirrhosis and renal function. J Hepatol (1995) 2.10
Neurovirulence of influenza virus in mice. I. Neurovirulence of recombinants between virulent and avirulent virus strains. Virology (1980) 2.10
Biopsy-induced tricuspid regurgitation after cardiac transplantation. Ann Thorac Surg (1994) 2.07
Erythromelalgia associated with Clitocybe acromelalga intoxication. Clin Toxicol (Phila) (2013) 2.03
A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem (1994) 2.03
Solitary fibrous tumour: significance of p53 and CD34 immunoreactivity in its malignant transformation. Histopathology (1998) 2.00
Transcriptional regulation of a periodically controlled flagellar gene operon in Caulobacter crescentus. J Mol Biol (1985) 1.96
Identification, nucleotide sequence, and control of developmentally regulated promoters in the hook operon region of Caulobacter crescentus. Proc Natl Acad Sci U S A (1986) 1.92
A set of positively regulated flagellar gene promoters in Caulobacter crescentus with sequence homology to the nif gene promoters of Klebsiella pneumoniae. J Mol Biol (1987) 1.92
Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J Biol Chem (1993) 1.86
Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. Pharmacogenetics (2001) 1.83
Guidelines for credentialing and granting privileges for endoscopic ultrasound. Gastrointest Endosc (2001) 1.81
Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med (1992) 1.80
Genetic interaction between hoxb-5 and hoxb-6 is revealed by nonallelic noncomplementation. Genes Dev (1995) 1.80
Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J Clin Invest (1993) 1.79
Carcinoma of the main hepatic duct junction: indications, operative morbidity and mortality, and long-term survival. Surgery (1990) 1.79
L-arginine-induced hypotension. Lancet (1990) 1.77
Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery (1994) 1.73
Cognitive decline in adulthood: an 11.5-year follow-up of the Baltimore Epidemiologic Catchment Area study. Am J Psychiatry (1999) 1.73
Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death. Cardiovasc Res (2001) 1.70
Modulation of QT interval by cardiac sympathetic nerve sprouting and the mechanisms of ventricular arrhythmia in a canine model of sudden cardiac death. J Cardiovasc Electrophysiol (2001) 1.70
Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation (1998) 1.69
Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am J Hum Genet (2000) 1.68
JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1. Proc Natl Acad Sci U S A (1999) 1.65
Hepatic resection for hepatocellular carcinoma. Surgery (1990) 1.64
How extensive should lymph node dissection be for cancer of the thoracic esophagus? J Thorac Cardiovasc Surg (1994) 1.61
Surgical management of temporomandibular joint ankylosis in the pediatric population. Plast Reconstr Surg (1993) 1.60
Structure of the human prealbumin gene. J Biol Chem (1985) 1.58
Arterial tonometry for noninvasive, continuous blood pressure monitoring during anesthesia. Anesthesiology (1991) 1.58
Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol (2009) 1.58
Liver transplantation using a right lobe graft from a living related donor. Transplantation (1994) 1.57
Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. Circulation (1998) 1.56
Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood (1996) 1.55
Smallpox vaccination reactions, prophylaxis, and therapy of complications. Pediatrics (1975) 1.55
Neointimal formation at the sites of anastomosis of the internal thoracic artery grafts after coronary artery bypass grafting in human subjects: an immunohistochemical analysis. J Thorac Cardiovasc Surg (2000) 1.54
Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin. Pharmacogenetics (2001) 1.53
Anti-tumor promoting action of phthalic acid mono-n-butyl ester cupric salt, a biomimetic superoxide dismutase. Carcinogenesis (1990) 1.49
Structure of the human ornithine transcarbamylase gene. J Biochem (1988) 1.49
Mechanisms of Igf2/H19 imprinting: DNA methylation, chromatin and long-distance gene regulation. J Biochem (2000) 1.48
A monoclonal antibody specifically reactive to human Langerhans cells. J Invest Dermatol (1986) 1.48
Crystal structure of a repair enzyme of oxidatively damaged DNA, MutM (Fpg), from an extreme thermophile, Thermus thermophilus HB8. EMBO J (2000) 1.48
Clinical significance of telomerase activity in the non-cancerous epithelial region of oesophageal squamous cell carcinoma. Br J Surg (1999) 1.47
Lymphomatous features of aggressive NK cell leukaemia/lymphoma with massive necrosis, haemophagocytosis and EB virus infection. Histopathology (2000) 1.47
L-arginine-induced hypotension. Lancet (1991) 1.47
Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol (1990) 1.47
Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res (1993) 1.47
Gene therapy of liver tumors with human liver-specific nanoparticles. Cancer Gene Ther (2006) 1.46
Isolation and expression of cloned hook protein gene from Caulobacter crescentus. Proc Natl Acad Sci U S A (1982) 1.46
Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice. Antimicrob Agents Chemother (1988) 1.46
Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs. J Pharm Sci (1992) 1.45
Nerve sprouting and sympathetic hyperinnervation in a canine model of atrial fibrillation produced by prolonged right atrial pacing. Circulation (2001) 1.45
Elevations of CK-MB following pulmonary embolism. A manifestation of occult right ventricular infarction. Chest (1992) 1.44
Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation. J Biol Chem (2001) 1.44
[Radiological study of the accessory skeletal elements in the foot and ankle (author's transl)]. Nihon Seikeigeka Gakkai Zasshi (1981) 1.44
Colocalization of tenascin and sympathetic nerves in a canine model of nerve sprouting and sudden cardiac death. J Cardiovasc Electrophysiol (2000) 1.43
Crystal structure of Thermus thermophilus HB8 UvrB protein, a key enzyme of nucleotide excision repair. J Biochem (1999) 1.43
Purification of the N-type calcium channel associated with syntaxin and synaptotagmin. A complex implicated in synaptic vesicle exocytosis. J Biol Chem (1994) 1.43
Catalase gene of the yeast Candida tropicalis. Sequence analysis and comparison with peroxisomal and cytosolic catalases from other sources. Eur J Biochem (1987) 1.42
Semilunar valve replacement with a cylindrical valve. J Card Surg (1993) 1.41
The origin of hypsarrhythmia and tonic spasms in West syndrome: evidence from a case of porencephaly and hydrocephalus with focal hypsarrhythmia. Brain Dev (1999) 1.40
Guidance with real-time CT fluoroscopy: early clinical experience. Radiology (1996) 1.40
Green fluorescent protein-transgenic rat: a tool for organ transplantation research. Biochem Biophys Res Commun (2001) 1.39
Intrauterine depressed skull fracture. A report of two cases. Pediatr Neurosci (1989) 1.39
Disseminated intravascular coagulation after hepatic resection. Surgery (1990) 1.39
Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa. Clin Pharmacol Ther (2007) 1.39
Efficacy of angioscopy in determining the effectiveness of intracoronary urokinase and TEC atherectomy thrombus removal from an occluded saphenous vein graft prior to stent implantation. Cathet Cardiovasc Diagn (1995) 1.39
Sex-related differences in drug metabolism. Drug Metab Rev (1974) 1.38
Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors. Inflamm Res (2006) 1.37
cDNA cloning of the hydroxysteroid sulfotransferase STa sharing a strong homology in amino acid sequence with the senescence marker protein SMP-2 in rat livers. Biochem Biophys Res Commun (1990) 1.37
Transcriptional activation of a ras-like gene (kir) by oncogenic tyrosine kinases. Proc Natl Acad Sci U S A (1994) 1.37
Studies on the mechanism of drug-induced microsomal enzyme activities. V. Phenobarbital stimulation of endogenous messenger RNA and polyuridylic acid-directed L-[14C]-phenylalanine incorporation. Mol Pharmacol (1966) 1.36
Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics (1977) 1.35
Electron microscope studies of the intracytoplasmic membrane system in Clostridium tetani and Clostridium botulinum. Jpn J Microbiol (1965) 1.34
Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. Cancer Res (1991) 1.34
Enrichment and efficient screening of ES cells containing a targeted mutation: the use of DT-A gene with the polyadenylation signal as a negative selection maker. Transgenic Res (1999) 1.33